Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1983 Aug;73(8):850-5.
doi: 10.2105/ajph.73.8.850.

The Seattle evaluation of computerized drug profiles: effects on prescribing practices and resource use

Clinical Trial

The Seattle evaluation of computerized drug profiles: effects on prescribing practices and resource use

T D Koepsell et al. Am J Public Health. 1983 Aug.

Abstract

Since 1979, all outpatient pharmacy transactions at the US Public Health Service Hospital in Seattle have been captured in a computer system which generates a profile of each patient's active and previously used drugs. We conducted a controlled trial in which patients were allocated to profile or no-profile groups while the computer continued to collect data on everyone. In all, 41,572 clinic visits made by 6,186 patients were studied. The incidence of preventable drug-drug interactions and redundancies was very low and was unaffected by profiles. For unclear reasons, prescription of two interacting drugs on the same visit was significantly more common for patients with profiles. The duration of drug-drug interaction episodes was significantly shorter for profile group patients, perhaps due to earlier detection of the error on subsequent visits. Profiles had no effect on prescribing volume or coordination of drug refill and visit schedules, but profile group patients made about 5 per cent fewer clinic visits than those in the no-profile group. In this setting, it appears that the prescribing of interacting or redundant drugs is more often due to inadequate provider knowledge than to inaccessible patient-specific drug data. Prevention of such errors would thus require a more active educational or monitoring program.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Med Care. 1976 Oct;14(10):799-807 - PubMed
    1. Med Care. 1978 May;16(5):408-16 - PubMed
    1. Biometrics. 1978 Dec;34(4):571-80 - PubMed
    1. Med Care. 1983 May;21(5):497-507 - PubMed

Publication types

LinkOut - more resources